{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T04:37:22Z","timestamp":1776487042368,"version":"3.51.2"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"24","license":[{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Foundation of Research, Technology and Development"},{"name":"Austrian Federal Ministry of Digital and Economic Affairs"},{"name":"State of Salzburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Manufacturing of biopharmaceuticals involves recombinant protein expression in host cells followed by extensive purification of the target protein. Yet, host cell proteins (HCPs) may persist in the final drug product, potentially reducing its quality with respect to safety and efficacy. Consequently, residual HCPs are closely monitored during downstream processing by techniques such as enzyme-linked immunosorbent assay (ELISA) or high-performance liquid chromatography combined with tandem mass spectrometry (HPLC-MS\/MS). The latter is especially attractive as it provides information with respect to protein identities. Although the applied HPLC-MS\/MS methodologies are frequently optimized with respect to HCP identification, acquired data is typically analyzed using standard settings. Here, we describe an improved strategy for evaluating HPLC-MS\/MS data of HCP-derived peptides, involving probabilistic protein inference and peptide detection in the absence of fragment ion spectra. This data analysis workflow was applied to data obtained for drug products of various biotherapeutics upon protein A affinity depletion. The presented data evaluation strategy enabled in-depth comparative analysis of the HCP repertoires identified in drug products of the monoclonal antibodies rituximab and bevacizumab, as well as the fusion protein etanercept. In contrast to commonly applied ELISA strategies, the here presented workflow is process-independent and may be implemented into existing HPLC-MS\/MS setups for drug product characterization and process development.<\/jats:p>","DOI":"10.1007\/s00216-020-02796-1","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T20:03:50Z","timestamp":1595275430000},"page":"6583-6593","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Exploring sample preparation and data evaluation strategies for enhanced identification of host cell proteins in drug products of therapeutic antibodies and Fc-fusion proteins"],"prefix":"10.1007","volume":"412","author":[{"given":"Wolfgang","family":"Esser-Skala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marius","family":"Segl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Therese","family":"Wohlschlager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"Reisinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann","family":"Holzmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian G.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,20]]},"reference":[{"issue":"2","key":"2796_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/s0021-9673(99)00613-5","volume":"852","author":"JE de Oliveira","year":"1999","unstructured":"de Oliveira JE, Soares CR, Peroni CN, Gimbo E, Camargo IM, Morganti L, et al. High-yield purification of biosynthetic human growth hormone secreted in Escherichia coli periplasmic space. J Chromatogr A. 1999;852(2):441\u201350. https:\/\/doi.org\/10.1016\/s0021-9673(99)00613-5.","journal-title":"J Chromatogr A"},{"issue":"3","key":"2796_CR2","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1021\/bp070452g","volume":"24","author":"U Gottschalk","year":"2008","unstructured":"Gottschalk U. Bioseparation in antibody manufacturing: the good, the bad and the ugly. Biotechnol Prog. 2008;24(3):496\u2013503. https:\/\/doi.org\/10.1021\/bp070452g.","journal-title":"Biotechnol Prog"},{"issue":"3","key":"2796_CR3","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1021\/bp070396j","volume":"24","author":"AA Shukla","year":"2008","unstructured":"Shukla AA, Jiang C, Ma J, Rubacha M, Flansburg L, Lee SS. Demonstration of robust host cell protein clearance in biopharmaceutical downstream processes. Biotechnol Prog. 2008;24(3):615\u201322. https:\/\/doi.org\/10.1021\/bp070396j.","journal-title":"Biotechnol Prog"},{"issue":"5","key":"2796_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.tibtech.2010.02.001","volume":"28","author":"AA Shukla","year":"2010","unstructured":"Shukla AA, Thommes J. Recent advances in large-scale production of monoclonal antibodies and related proteins. Trends Biotechnol. 2010;28(5):253\u201361. https:\/\/doi.org\/10.1016\/j.tibtech.2010.02.001.","journal-title":"Trends Biotechnol"},{"key":"2796_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.chroma.2016.01.047","volume":"1438","author":"B Tran","year":"2016","unstructured":"Tran B, Grosskopf V, Wang X, Yang J, Walker D Jr, Yu C, et al. Investigating interactions between phospholipase B-like 2 and antibodies during protein A chromatography. J Chromatogr A. 2016;1438:31\u20138. https:\/\/doi.org\/10.1016\/j.chroma.2016.01.047.","journal-title":"J Chromatogr A"},{"issue":"1","key":"2796_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/btpr.537","volume":"27","author":"H Dorai","year":"2011","unstructured":"Dorai H, Santiago A, Campbell M, Tang QM, Lewis MJ, Wang Y, et al. Characterization of the proteases involved in the N-terminal clipping of glucagon-like-peptide-1-antibody fusion proteins. Biotechnol Prog. 2011;27(1):220\u201331. https:\/\/doi.org\/10.1002\/btpr.537.","journal-title":"Biotechnol Prog"},{"issue":"4","key":"2796_CR7","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/bit.22982","volume":"108","author":"SX Gao","year":"2011","unstructured":"Gao SX, Zhang Y, Stansberry-Perkins K, Buko A, Bai S, Nguyen V, et al. Fragmentation of a highly purified monoclonal antibody attributed to residual CHO cell protease activity. Biotechnol Bioeng. 2011;108(4):977\u201382. https:\/\/doi.org\/10.1002\/bit.22982.","journal-title":"Biotechnol Bioeng"},{"issue":"9","key":"2796_CR8","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.4161\/hv.22378","volume":"8","author":"AH Gutierrez","year":"2012","unstructured":"Gutierrez AH, Moise L, De Groot AS. Of [Hamsters] and men: a new perspective on host cell proteins. Hum Vaccin Immunother. 2012;8(9):1172\u20134. https:\/\/doi.org\/10.4161\/hv.22378.","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"2796_CR9","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.xphs.2016.02.022","volume":"105","author":"T Hall","year":"2016","unstructured":"Hall T, Sandefur SL, Frye CC, Tuley TL, Huang L. Polysorbates 20 and 80 degradation by group XV lysosomal phospholipase A2 isomer X1 in monoclonal antibody formulations. J Pharm Sci. 2016;105(5):1633\u201342. https:\/\/doi.org\/10.1016\/j.xphs.2016.02.022.","journal-title":"J Pharm Sci"},{"issue":"3","key":"2796_CR10","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/bit.22699","volume":"106","author":"M Trexler-Schmidt","year":"2010","unstructured":"Trexler-Schmidt M, Sargis S, Chiu J, Sze-Khoo S, Mun M, Kao YH, et al. Identification and prevention of antibody disulfide bond reduction during cell culture manufacturing. Biotechnol Bioeng. 2010;106(3):452\u201361. https:\/\/doi.org\/10.1002\/bit.22699.","journal-title":"Biotechnol Bioeng"},{"issue":"4","key":"2796_CR11","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1002\/btpr.2640","volume":"34","author":"M Vanderlaan","year":"2018","unstructured":"Vanderlaan M, Zhu-Shimoni J, Lin S, Gunawan F, Waerner T, Van Cott KE. Experience with host cell protein impurities in biopharmaceuticals. Biotechnol Prog. 2018;34(4):828\u201337. https:\/\/doi.org\/10.1002\/btpr.2640.","journal-title":"Biotechnol Prog"},{"issue":"3","key":"2796_CR12","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/0006-291x(91)90635-k","volume":"177","author":"MR Wilson","year":"1991","unstructured":"Wilson MR, Roeth PJ, Easterbrook-Smith SB. Clusterin enhances the formation of insoluble immune complexes. Biochem Biophys Res Commun. 1991;177(3):985\u201390. https:\/\/doi.org\/10.1016\/0006-291x(91)90635-k.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2796_CR13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1208\/s12248-016-9998-7","volume":"19","author":"SK Fischer","year":"2017","unstructured":"Fischer SK, Cheu M, Peng K, Lowe J, Araujo J, Murray E, et al. Specific immune response to phospholipase B-like 2 protein, a host cell impurity in lebrikizumab clinical material. AAPS J. 2017;19(1):254\u201363. https:\/\/doi.org\/10.1208\/s12248-016-9998-7.","journal-title":"AAPS J"},{"issue":"4","key":"2796_CR14","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1055\/s-0037-1613059","volume":"87","author":"J Ingerslev","year":"2002","unstructured":"Ingerslev J, Christiansen K, Ravn HB, Bray GL, Gomperts ED, Recombinate SG. Antibodies to heterologous proteins in hemophilia A patients receiving recombinant factor VIII (Recombinate). Thromb Haemost. 2002;87(4):626\u201334.","journal-title":"Thromb Haemost"},{"issue":"9","key":"2796_CR15","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/bit.25628","volume":"112","author":"DG Bracewell","year":"2015","unstructured":"Bracewell DG, Francis R, Smales CM. The future of host cell protein (HCP) identification during process development and manufacturing linked to a risk-based management for their control. Biotechnol Bioeng. 2015;112(9):1727\u201337. https:\/\/doi.org\/10.1002\/bit.25628.","journal-title":"Biotechnol Bioeng"},{"issue":"3","key":"2796_CR16","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/bit.22304","volume":"103","author":"X Wang","year":"2009","unstructured":"Wang X, Hunter AK, Mozier NM. Host cell proteins in biologics development: identification, quantitation and risk assessment. Biotechnol Bioeng. 2009;103(3):446\u201358. https:\/\/doi.org\/10.1002\/bit.22304.","journal-title":"Biotechnol Bioeng"},{"issue":"2","key":"2796_CR17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0022-1759(86)90481-3","volume":"91","author":"VR Anicetti","year":"1986","unstructured":"Anicetti VR, Fehskens EF, Reed BR, Chen AB, Moore P, Geier MD, et al. Immunoassay for the detection of E. coli proteins in recombinant DNA derived human growth hormone. J Immunol Methods. 1986;91(2):213\u201324. https:\/\/doi.org\/10.1016\/0022-1759(86)90481-3.","journal-title":"J Immunol Methods"},{"issue":"1\u20132","key":"2796_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/s0022-1759(01)00321-0","volume":"251","author":"N Dagouassat","year":"2001","unstructured":"Dagouassat N, Haeuw JF, Robillard V, Damien F, Libon C, Corvaia N, et al. Development of a quantitative assay for residual host cell proteins in a recombinant subunit vaccine against human respiratory syncytial virus. J Immunol Methods. 2001;251(1\u20132):151\u20139. https:\/\/doi.org\/10.1016\/s0022-1759(01)00321-0.","journal-title":"J Immunol Methods"},{"key":"2796_CR19","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jpba.2012.05.027","volume":"70","author":"G Rey","year":"2012","unstructured":"Rey G, Wendeler MW. Full automation and validation of a flexible ELISA platform for host cell protein and protein A impurity detection in biopharmaceuticals. J Pharm Biomed Anal. 2012;70:580\u20136. https:\/\/doi.org\/10.1016\/j.jpba.2012.05.027.","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"2796_CR20","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/pmic.200500225","volume":"6","author":"DC Krawitz","year":"2006","unstructured":"Krawitz DC, Forrest W, Moreno GT, Kittleson J, Champion KM. Proteomic studies support the use of multi-product immunoassays to monitor host cell protein impurities. Proteomics. 2006;6(1):94\u2013110. https:\/\/doi.org\/10.1002\/pmic.200500225.","journal-title":"Proteomics."},{"issue":"2","key":"2796_CR21","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/bit.26466","volume":"115","author":"F Gunawan","year":"2018","unstructured":"Gunawan F, Nishihara J, Liu P, Sandoval W, Vanderlaan M, Zhang H, et al. Comparison of platform host cell protein ELISA to process-specific host cell protein ELISA. Biotechnol Bioeng. 2018;115(2):382\u20139. https:\/\/doi.org\/10.1002\/bit.26466.","journal-title":"Biotechnol Bioeng"},{"key":"2796_CR22","doi-asserted-by":"publisher","unstructured":"Pilely K, Nielsen SB, Draborg A, Henriksen ML, Hansen SWK, Skriver L, et al. A Novel Approach to Evaluate ELISA Antibody Coverage of Host Cell Proteins - Combining ELISA-based Immunocapture and Mass Spectrometry. Biotechnol Prog. 2020;in press. https:\/\/doi.org\/10.1002\/btpr.2983.","DOI":"10.1002\/btpr.2983"},{"issue":"12","key":"2796_CR23","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1002\/bit.25327","volume":"111","author":"J Zhu-Shimoni","year":"2014","unstructured":"Zhu-Shimoni J, Yu C, Nishihara J, Wong RM, Gunawan F, Lin M, et al. Host cell protein testing by ELISAs and the use of orthogonal methods. Biotechnol Bioeng. 2014;111(12):2367\u201379. https:\/\/doi.org\/10.1002\/bit.25327.","journal-title":"Biotechnol Bioeng"},{"issue":"11","key":"2796_CR24","doi-asserted-by":"publisher","first-page":"e81639","DOI":"10.1371\/journal.pone.0081639","volume":"8","author":"K Bomans","year":"2013","unstructured":"Bomans K, Lang A, Roedl V, Adolf L, Kyriosoglou K, Diepold K, et al. Identification and monitoring of host cell proteins by mass spectrometry combined with high performance immunochemistry testing. PLoS One. 2013;8(11):e81639. https:\/\/doi.org\/10.1371\/journal.pone.0081639.","journal-title":"PLoS One"},{"issue":"2","key":"2796_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ab.2012.05.018","volume":"428","author":"MR Schenauer","year":"2012","unstructured":"Schenauer MR, Flynn GC, Goetze AM. Identification and quantification of host cell protein impurities in biotherapeutics using mass spectrometry. Anal Biochem. 2012;428(2):150\u20137. https:\/\/doi.org\/10.1016\/j.ab.2012.05.018.","journal-title":"Anal Biochem"},{"issue":"10","key":"2796_CR26","doi-asserted-by":"publisher","first-page":"5294","DOI":"10.1021\/acs.analchem.6b04892","volume":"89","author":"S Kreimer","year":"2017","unstructured":"Kreimer S, Gao Y, Ray S, Jin M, Tan Z, Mussa NA, et al. Host cell protein profiling by targeted and untargeted analysis of data independent acquisition mass spectrometry data with parallel reaction monitoring verification. Anal Chem. 2017;89(10):5294\u2013302. https:\/\/doi.org\/10.1021\/acs.analchem.6b04892.","journal-title":"Anal Chem"},{"issue":"6","key":"2796_CR27","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1586\/14789450.3.6.611","volume":"3","author":"L Wu","year":"2006","unstructured":"Wu L, Han DK. Overcoming the dynamic range problem in mass spectrometry-based shotgun proteomics. Expert Rev Proteomics. 2006;3(6):611\u20139. https:\/\/doi.org\/10.1586\/14789450.3.6.611.","journal-title":"Expert Rev Proteomics"},{"issue":"13","key":"2796_CR28","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1021\/ac020361s","volume":"75","author":"BK Matuszewski","year":"2003","unstructured":"Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS. Anal Chem. 2003;75(13):3019\u201330. https:\/\/doi.org\/10.1021\/ac020361s.","journal-title":"Anal Chem"},{"key":"2796_CR29","doi-asserted-by":"publisher","unstructured":"Doneanu C, Fang J, Alelyunas Y, Yu YQ, Wrona M, Chen W. An HS-MRM assay for the quantification of host-cell proteins in protein biopharmaceuticals by liquid chromatography ion mobility QTOF mass spectrometry. J Vis Exp. 2018;134. https:\/\/doi.org\/10.3791\/55325.","DOI":"10.3791\/55325"},{"issue":"20","key":"2796_CR30","doi-asserted-by":"publisher","first-page":"10283","DOI":"10.1021\/acs.analchem.5b02103","volume":"87","author":"CE Doneanu","year":"2015","unstructured":"Doneanu CE, Anderson M, Williams BJ, Lauber MA, Chakraborty A, Chen W. Enhanced detection of low-abundance host cell protein impurities in high-purity monoclonal antibodies down to 1 ppm using ion mobility mass spectrometry coupled with multidimensional liquid chromatography. Anal Chem. 2015;87(20):10283\u201391. https:\/\/doi.org\/10.1021\/acs.analchem.5b02103.","journal-title":"Anal Chem"},{"issue":"18","key":"2796_CR31","doi-asserted-by":"publisher","first-page":"9186","DOI":"10.1021\/acs.analchem.5b01377","volume":"87","author":"A Farrell","year":"2015","unstructured":"Farrell A, Mittermayr S, Morrissey B, Mc Loughlin N, Navas Iglesias N, Marison IW, et al. Quantitative host cell protein analysis using two dimensional data independent LC-MS(E). Anal Chem. 2015;87(18):9186\u201393. https:\/\/doi.org\/10.1021\/acs.analchem.5b01377.","journal-title":"Anal Chem"},{"issue":"1","key":"2796_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4161\/mabs.4.1.18748","volume":"4","author":"CE Doneanu","year":"2012","unstructured":"Doneanu CE, Xenopoulos A, Fadgen K, Murphy J, Skilton SJ, Prentice H, et al. Analysis of host-cell proteins in biotherapeutic proteins by comprehensive online two-dimensional liquid chromatography\/mass spectrometry. MAbs. 2012;4(1):24\u201344. https:\/\/doi.org\/10.4161\/mabs.4.1.18748.","journal-title":"MAbs."},{"issue":"10","key":"2796_CR33","doi-asserted-by":"publisher","first-page":"5387","DOI":"10.1021\/acs.analchem.5b00708","volume":"87","author":"RJ Vonk","year":"2015","unstructured":"Vonk RJ, Gargano AF, Davydova E, Dekker HL, Eeltink S, de Koning LJ, et al. Comprehensive two-dimensional liquid chromatography with stationary-phase-assisted modulation coupled to high-resolution mass spectrometry applied to proteome analysis of Saccharomyces cerevisiae. Anal Chem. 2015;87(10):5387\u201394. https:\/\/doi.org\/10.1021\/acs.analchem.5b00708.","journal-title":"Anal Chem"},{"issue":"1","key":"2796_CR34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jchromb.2006.09.030","volume":"848","author":"S Hober","year":"2007","unstructured":"Hober S, Nord K, Linhult M. Protein A chromatography for antibody purification. J Chromatogr B Anal Technol Biomed Life Sci. 2007;848(1):40\u20137. https:\/\/doi.org\/10.1016\/j.jchromb.2006.09.030.","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"issue":"8","key":"2796_CR35","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/rcm.6854","volume":"28","author":"JH Thompson","year":"2014","unstructured":"Thompson JH, Chung WK, Zhu M, Tie L, Lu Y, Aboulaich N, et al. Improved detection of host cell proteins (HCPs) in a mammalian cell-derived antibody drug using liquid chromatography\/mass spectrometry in conjunction with an HCP-enrichment strategy. Rapid Commun Mass Spectrom. 2014;28(8):855\u201360. https:\/\/doi.org\/10.1002\/rcm.6854.","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"6","key":"2796_CR36","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1080\/19420862.2015.1082017","volume":"7","author":"JA Madsen","year":"2015","unstructured":"Madsen JA, Farutin V, Carbeau T, Wudyka S, Yin Y, Smith S, et al. Toward the complete characterization of host cell proteins in biotherapeutics via affinity depletions, LC-MS\/MS, and multivariate analysis. MAbs. 2015;7(6):1128\u201337. https:\/\/doi.org\/10.1080\/19420862.2015.1082017.","journal-title":"MAbs."},{"issue":"5","key":"2796_CR37","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.drudis.2016.01.006","volume":"21","author":"P Zhang","year":"2016","unstructured":"Zhang P, Woen S, Wang T, Liau B, Zhao S, Chen C, et al. Challenges of glycosylation analysis and control: an integrated approach to producing optimal and consistent therapeutic drugs. Drug Discov Today. 2016;21(5):740\u201365. https:\/\/doi.org\/10.1016\/j.drudis.2016.01.006.","journal-title":"Drug Discov Today"},{"issue":"5","key":"2796_CR38","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1002\/btpr.1948","volume":"30","author":"N Aboulaich","year":"2014","unstructured":"Aboulaich N, Chung WK, Thompson JH, Larkin C, Robbins D, Zhu M. A novel approach to monitor clearance of host cell proteins associated with monoclonal antibodies. Biotechnol Prog. 2014;30(5):1114\u201324. https:\/\/doi.org\/10.1002\/btpr.1948.","journal-title":"Biotechnol Prog"},{"issue":"11","key":"2796_CR39","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1002\/bit.25639","volume":"112","author":"S Chollangi","year":"2015","unstructured":"Chollangi S, Parker R, Singh N, Li Y, Borys M, Li Z. Development of robust antibody purification by optimizing protein-A chromatography in combination with precipitation methodologies. Biotechnol Bioeng. 2015;112(11):2292\u2013304. https:\/\/doi.org\/10.1002\/bit.25639.","journal-title":"Biotechnol Bioeng"},{"issue":"5","key":"2796_CR40","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/btpr.50","volume":"24","author":"AA Shukla","year":"2008","unstructured":"Shukla AA, Hinckley P. Host cell protein clearance during protein A chromatography: development of an improved column wash step. Biotechnol Prog. 2008;24(5):1115\u201321. https:\/\/doi.org\/10.1002\/btpr.50.","journal-title":"Biotechnol Prog"},{"key":"2796_CR41","doi-asserted-by":"publisher","unstructured":"Chen IH, Xiao H, Daly T, Li N. Improved host cell protein analysis in monoclonal antibody products through molecular weight cutoff enrichment. Anal Chem. 2020. https:\/\/doi.org\/10.1021\/acs.analchem.9b05081.","DOI":"10.1021\/acs.analchem.9b05081"},{"issue":"12","key":"2796_CR42","doi-asserted-by":"publisher","first-page":"5296","DOI":"10.1021\/pr200780j","volume":"10","author":"MW Bern","year":"2011","unstructured":"Bern MW, Kil YJ. Two-dimensional target decoy strategy for shotgun proteomics. J Proteome Res. 2011;10(12):5296\u2013301. https:\/\/doi.org\/10.1021\/pr200780j.","journal-title":"J Proteome Res"},{"issue":"4","key":"2796_CR43","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/1044-0305(95)00017-8","volume":"6","author":"MW Senko","year":"1995","unstructured":"Senko MW, Beu SC, McLaffertycor FW. Determination of monoisotopic masses and ion populations for large biomolecules from resolved isotopic distributions. J Am Soc Mass Spectrom. 1995;6(4):229\u201333. https:\/\/doi.org\/10.1016\/1044-0305(95)00017-8.","journal-title":"J Am Soc Mass Spectrom"},{"key":"2796_CR44","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Founcation for statistical Computing. 2019."},{"key":"2796_CR45","doi-asserted-by":"publisher","unstructured":"Wickham H, Averick M, Bryan J, Chang W, McGowan L, Fran\u00e7ois R, et al. Welcome to the Tidyverse. J Open Source Softw. 2019;4(43). https:\/\/doi.org\/10.21105\/joss.01686.","DOI":"10.21105\/joss.01686"},{"issue":"2","key":"2796_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nmeth.3252","volume":"12","author":"W Huber","year":"2015","unstructured":"Huber W, Carey VJ, Gentleman R, Anders S, Carlson M, Carvalho BS, et al. Orchestrating high-throughput genomic analysis with bioconductor. Nat Methods. 2015;12(2):115\u201321. https:\/\/doi.org\/10.1038\/nmeth.3252.","journal-title":"Nat Methods"},{"key":"2796_CR47","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/02648725.2001.10648017","volume":"18","author":"RL Fahrner","year":"2001","unstructured":"Fahrner RL, Knudsen HL, Basey CD, Galan W, Feuerhelm D, Vanderlaan M, et al. Industrial purification of pharmaceutical antibodies: development, operation, and validation of chromatography processes. Biotechnol Genet Eng Rev. 2001;18:301\u201327. https:\/\/doi.org\/10.1080\/02648725.2001.10648017.","journal-title":"Biotechnol Genet Eng Rev"},{"issue":"10","key":"2796_CR48","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/biot.201100479","volume":"7","author":"VN Sisodiya","year":"2012","unstructured":"Sisodiya VN, Lequieu J, Rodriguez M, McDonald P, Lazzareschi KP. Studying host cell protein interactions with monoclonal antibodies using high throughput protein A chromatography. Biotechnol J. 2012;7(10):1233\u201341. https:\/\/doi.org\/10.1002\/biot.201100479.","journal-title":"Biotechnol J"},{"issue":"6","key":"2796_CR49","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/bit.26256","volume":"114","author":"AS Thomson","year":"2017","unstructured":"Thomson AS, Mai S, Byrne MP. A novel approach to characterize host cell proteins associated with therapeutic monoclonal antibodies. Biotechnol Bioeng. 2017;114(6):1208\u201314. https:\/\/doi.org\/10.1002\/bit.26256.","journal-title":"Biotechnol Bioeng"},{"issue":"5","key":"2796_CR50","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/bib\/bbs004","volume":"13","author":"T Huang","year":"2012","unstructured":"Huang T, Wang J, Yu W, He Z. Protein inference: a review. Brief Bioinform. 2012;13(5):586\u2013614. https:\/\/doi.org\/10.1093\/bib\/bbs004.","journal-title":"Brief Bioinform"},{"issue":"Suppl 16","key":"2796_CR51","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/1471-2105-13-S16-S4","volume":"13","author":"YF Li","year":"2012","unstructured":"Li YF, Radivojac P. Computational approaches to protein inference in shotgun proteomics. BMC Bioinformatics. 2012;13(Suppl 16):S4. https:\/\/doi.org\/10.1186\/1471-2105-13-S16-S4.","journal-title":"BMC Bioinformatics"},{"issue":"7","key":"2796_CR52","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1089\/cmb.2007.0119","volume":"15","author":"M Bern","year":"2008","unstructured":"Bern M, Goldberg D. Improved ranking functions for protein and modification-site identifications. J Comput Biol. 2008;15(7):705\u201319. https:\/\/doi.org\/10.1089\/cmb.2007.0119.","journal-title":"J Comput Biol"},{"issue":"9","key":"2796_CR53","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/S1044-0305(03)00146-6","volume":"14","author":"EF Strittmatter","year":"2003","unstructured":"Strittmatter EF, Ferguson PL, Tang K, Smith RD. Proteome analyses using accurate mass and elution time peptide tags with capillary LC time-of-flight mass spectrometry. J Am Soc Mass Spectrom. 2003;14(9):980\u201391. https:\/\/doi.org\/10.1016\/S1044-0305(03)00146-6.","journal-title":"J Am Soc Mass Spectrom"},{"issue":"4","key":"2796_CR54","doi-asserted-by":"publisher","first-page":"621","DOI":"10.2144\/04374RV01","volume":"37","author":"L Pasa-Tolic","year":"2004","unstructured":"Pasa-Tolic L, Masselon C, Barry RC, Shen Y, Smith RD. Proteomic analyses using an accurate mass and time tag strategy. BioTechniques. 2004;37(4):621\u20134, 6\u201333, 36 passim. https:\/\/doi.org\/10.2144\/04374RV01.","journal-title":"BioTechniques"},{"key":"2796_CR55","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.copbio.2018.01.004","volume":"53","author":"KN Valente","year":"2018","unstructured":"Valente KN, Levy NE, Lee KH, Lenhoff AM. Applications of proteomic methods for CHO host cell protein characterization in biopharmaceutical manufacturing. Curr Opin Biotechnol. 2018;53:144\u201350. https:\/\/doi.org\/10.1016\/j.copbio.2018.01.004.","journal-title":"Curr Opin Biotechnol"},{"key":"2796_CR56","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jpba.2019.06.021","volume":"174","author":"X Liu","year":"2019","unstructured":"Liu X, Chen Y, Zhao Y, Liu-Compton V, Chen W, Payne G, et al. Identification and characterization of co-purifying CHO host cell proteins in monoclonal antibody purification process. J Pharm Biomed Anal. 2019;174:500\u20138. https:\/\/doi.org\/10.1016\/j.jpba.2019.06.021.","journal-title":"J Pharm Biomed Anal"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-020-02796-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00216-020-02796-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-020-02796-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T23:20:04Z","timestamp":1626736804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00216-020-02796-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,20]]},"references-count":56,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["2796"],"URL":"https:\/\/doi.org\/10.1007\/s00216-020-02796-1","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,20]]},"assertion":[{"value":"15 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Veronika Reisinger and Johann Holzmann are employees of Novartis, which provides financial support for the Christian Doppler Laboratory for Innovative Tools for Biosimilar Characterization. The salaries of Wolfgang Esser-Skala, Marius Segl, and Therese Wohlschlager are fully funded; Christian G. Huber\u2019s salary is partly funded by the Christian Doppler Laboratory for Biosimilar Characterization. The authors declare that they have no other financial or non-financial conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}